Share the Video:

Visionary Women: Transforming Psychedelic Medicine

Rachel Yehuda

Vicky Dulai, founder of Compassion For Addiction, a non-profit dedicated to a trauma informed and psychedelic medicine approach to treating addiction, and board member of MAPS, will moderate a discussion with Amy Emerson, CEO of MAPS Public Benefit Corporation, and Rachel Yehuda, Ph.D., an endowed professor of Psychiatry and Neuroscience of Trauma at Icahn School of Medicine at Mount Sinai. The women will talk about lessons they have learned along the way and how they are leading the way in the psychedelic space.

Become a MAPS Member with a monthly donation

As a Member, you’re not just making a donation — you’re joining a community that is at the forefront of advancing research, changing policy, and evolving education around psychedelics. Join us in shaping a future where these life-changing tools are available to those who need them most.

Safety and accountability in psychedelic communities

Dr. Smith and Dr. Jones explore advancements in psychedelic research and therapy, highlighting key findings and implications for mental health treatment.

Hannah McLane, Brad Adams

PS2023 MDMA Policy and Advocacy Psychedelic Assisted Therapy Psychedelic Science Public Benefit Research

Preview Scene from Prescription X: The Rick Doblin and MAPS Documentary (Work in Progress)

"Prescription X: The Rick Doblin Story" documents Dr. Rick Doblin's quest with MAPS to legalize MDMA and psychedelics for therapy, culminating in a revealing film by Nirvan and Dream Mullick.

Nirvan Mullick, Dream Mullick

PS2023 Healing for All Policy and Advocacy Psychedelic Assisted Therapy Psychedelic Science Public Benefit Research

An Overview of Current State Frameworks for Psychedelic Healing

Leaders of Oregon and Colorado campaigns discuss the historic creation of state frameworks for psychedelic healing, detailing the journey, current status, and future directions. Total words: 26

Kevin Matthews, Joshua Kappel

PS2023 Policy and Advocacy Psychedelic Assisted Therapy Psychedelic Science Public Benefit Research Social and Cultural

Psychedelic education today: kids, parents, and the public

Panel discusses equipping parents with youth drug use info, fostering open conversations, and addressing public perception. Transformative drug education empowers communities, dismantles stigma, and cultivates informed society.

Vilmarie Narloch, Rhana Hashemi, Stefanie Jones, Gina Giorgio

PS2023 Policy and Advocacy Psychedelic Assisted Therapy Psychedelic Science Public Benefit Research Social Justice

TREAT CALIFORNIA-Providing $5 Billion to Fund Psychedelic Research and Therapies

TREAT California initiative aims to transform mental healthcare in California with $5 Billion funding for psychedelic medicine research and access, inspired by successful stem cell agency model.

Jeannie Moller Fontana

PS2023 Policy and Advocacy Psychedelic Science Public Benefit Research Social Justice State Policy

Building momentum for new state policy approaches

Expansion of psychedelic policy in the US includes decriminalization, adult use regulations, and increased research funding. Elected state lawmakers discuss challenges, opportunities, and lessons from proposed psychedelic legislation.

Rep La Shawn Ford (IL), Rep Alex Dominguez (TX), Tamar Todd

PS2023 Harm Reduction Policy and Advocacy Psychedelic Science Public Benefit Research Social Justice

Giving and growth: the role of philanthropic funding in the psychedelic sector

Philanthropy and investors can support crucial psychedelic research and initiatives beyond commercial interests to shape the field and promote equity and social value in the psychedelic economy.

Sandy Samberg

PS2023 Policy and Advocacy Psychedelic Science Public Benefit Research Social Justice

Visionary approaches: psychedelic policy in a global context

International drug policy, historically mirroring US prohibitionist approach, is evolving. Leaders propose regulatory solutions in context of broader drug reform for unified post-prohibition world.

Steve Rolles, Kasia Malinowska

PS2023 Policy and Advocacy Psychedelic Science Public Benefit Research Social Justice

Designing a post-prohibition future

Harms of drug prohibition include trauma and research prevention. Policies should shift focus from criminalizing psychedelics to supporting safe, beneficial use, fostering an imaginative world for future generations.

Ariel Clark, Christopher Medina-Kirchner, Roman Haferd, Betty Aldworth, Paula Graciela Kahn

Visionary Women: Transforming Psychedelic Medicine

Become a MAPS Member with a monthly donation

Related Videos